InsiderTrades

Form 4 for BBIO BridgeBio Pharma, Inc.

Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0000899243-21-033438 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-18 2021-08-16 BBIO Kumar Neil CEO, Pres, Dir F - Tax $49.48 -3,730 4.72M -0.1% -$184.6K
D 2021-08-18 2021-08-16 BBIO Kumar Neil CEO, Pres, Dir M - OptEx — +7,523 4.72M +0.2% —
DM 2021-08-18 2021-08-16 BBIO Kumar Neil CEO, Pres, Dir M - OptEx $0.00 -7,523 33.5K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-16 F D 3,730 $49.48 4,719,011 D — — (F2) Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,523 shares of Common Stock underlying the Reporting Person's RSUs.
2 Common Common Stock 2021-08-16 M A 7,523 — 4,722,741 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
3 Derivative Restricted Stock Units 2021-08-16 M D 5,129 $0.00 56,423 D — · — to — 5,129 Common Stock (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F5) The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
4 Derivative Restricted Stock Units 2021-08-16 M D 2,394 $0.00 33,518 D — · — to — 2,394 Common Stock (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F6) The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.